Related Experiment Video
Updated: Feb 16, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Increased expression of PRKCB mRNA in peripheral blood mononuclear cells from patients with systemic lupus
Zhengwei Zhu1, Lulu Yang1, Yaohua Zhang2
1Institute of Dermatology and Department of Dermatology, the First Affiliated Hospital, Anhui Medical University, Hefei, Anhui, China.
Abstract:
The polymorphism of PRKCB has been proven to be associated with systemic lupus erythematosus (SLE) in our previous study. We aimed to investigate the relationship between expression of PRKCB mRNA and the Disease Activity Index (SLEDAI) and manifestations of SLE. Quantitative reverse transcription polymerase chain reaction (RT-PCR) was applied to examine the expression of PRKCB mRNA in peripheral blood mononuclear cells of 60 patients with SLE and 62 controls. The Sequenom MassArray System was used to detect genotype SNP rs16972959. The expression levels of PRKCB mRNA in SLE cases were significantly increased compared with those in healthy controls (P < 0.001). In addition, PRKCB mRNA expression levels were negatively correlated with the SLEDAI (P < 0.05, r = -0.322), with lower mRNA expression levels of PRKCB in patients found with higher SLEDAI, presence of a new rash (P < 0.01), and proteinuria (P < 0.05). No association evidence was observed between the genotype of the variant rs16972959 and PRKCB mRNA expression levels; however, SNP rs16972959 was found to be an expression quantitative trait loci for PRKCB with the SLE risk allele correlated with increased expression in naïve monocytes (PFDR = 9.12 × 10-13 ) and stimulated monocytes (9.24 × 10-6 > PFDR > 2.75 × 10-17 ). On the other hand, SNP rs16972959 of PRKCB was found to have suggestive significant associations with vasculitis (P = 0.00718) of SLE. These results indicated that expression of PRKCB mRNA may be correlated with the pathogenesis of SLE; however, more investigation is still needed.
Insights
Increased PRKCB mRNA expression is linked to systemic lupus erythematosus (SLE), but negatively correlates with disease activity. This suggests PRKCB mRNA
Area of Science:
- Immunology
- Genetics
- Molecular Biology
Background:
- Previous studies linked PRKCB gene polymorphism to systemic lupus erythematosus (SLE).
- The role of PRKCB mRNA expression in SLE pathogenesis requires further investigation.
Purpose of the Study:
- To investigate the relationship between PRKCB mRNA expression and SLE disease activity (SLEDAI) and clinical manifestations.
- To explore the association between the PRKCB rs16972959 polymorphism and PRKCB mRNA expression levels in SLE patients.
Main Methods:
- Quantitative reverse transcription polymerase chain reaction (RT-PCR) to measure PRKCB mRNA levels in 60 SLE patients and 62 controls.
- Sequenom MassArray System to genotype the PRKCB rs16972959 single nucleotide polymorphism (SNP).
Main Results:
- PRKCB mRNA expression was significantly higher in SLE patients than in controls (P < 0.001).
- PRKCB mRNA levels showed a negative correlation with SLEDAI (r = -0.322, P < 0.05), indicating lower expression with higher disease activity.
- Lower PRKCB mRNA expression was associated with rash and proteinuria in SLE patients.
- The rs16972959 SNP was an expression quantitative trait locus (eQTL) for PRKCB, with the SLE risk allele increasing expression in monocytes.
- The rs16972959 SNP showed a suggestive association with vasculitis in SLE (P = 0.00718).
Conclusions:
- PRKCB mRNA expression may play a role in the pathogenesis of SLE.
- Further research is needed to elucidate the precise role of PRKCB in SLE development and progression.
Related Concept Videos
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
mRNA Stability and Gene Expression
Cell Specific Gene Expression
Regulated mRNA Transport
Nuclear Export of mRNA
pre-mRNA Processing
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a “cap” to the 5’ end of the growing transcript. In this process, a 5’ phosphate is replaced by modified guanosine that has a methyl group attached to it (7-Methyl...

